Type
1.
Dubey A, Biswas SK, Sinha E, Chakma JK, Kamal R, Arora M, et al. Association of Nitric Oxide Synthase2 gene polymorphisms with leprosy reactions in northern Indian population. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2017;
Type
1.
Oliveira ALG, Chaves AT, Menezes CAS, Guimarães NS, Bueno LL, Fujiwara RT, et al. Vitamin D Receptor Expression and Hepcidin Levels in the Protection or Severity of Leprosy: a Systematic Review. Microbes and infection. 2017;
Type
1.
Sousa JR, Sousa RPM, Aarão TLS, Dias LB, Oliveira Carneiro FR, Quaresma JAS. Response of iNOS and its relationship with IL-22 and STAT3 in macrophage activity in the polar forms of leprosy. Acta tropica. 2017;
Type
1.
Lima Santana N, Rêgo JL, Oliveira JM, Almeida LF, Braz M, Machado LMM, et al. Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy. Memorias do Instituto Oswaldo Cruz [Internet]. 2017;112(4):260-8. Available from: http://www.scielo.br/pdf/mioc/v112n4/0074-0276-mioc-0074-02760160366.pdf
Type
1.
Phillips DA, Ferreira JA, Ansah D, Teixeira HS, Kitron U, Filippis T, et al. A tale of two neglected tropical infections: using GIS to assess the spatial and temporal overlap of schistosomiasis and leprosy in a region of Minas Gerais, Brazil. Memorias do Instituto Oswaldo Cruz [Internet]. 2017;112(4):275-80. Available from: http://www.scielo.br/pdf/mioc/v112n4/0074-0276-mioc-112-4-0275.pdf
Type
1.
Walsh D, Jong B, Meyers W, Portaels F. Leprosy and Buruli ulcer: similarities suggest combining control and prevention of disability strategies in countries endemic for both diseases. Leprosy review [Internet]. 2015;86(1):1-5. Available from: https://leprosyreview.org/article/86/1/00-1005
Type
1.
Nsagha D, Bissek A-C, Nsagha S, Njunda A, Assob J, Tabah E, et al. Social stigma as an epidemiological determinant for leprosy elimination in Cameroon. Journal of public health in Africa [Internet]. 2011;2(1):e10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345469/pdf/jphia-2011-1-e10.pdf
Type
1.
Bense N, Das P, Rao PSS, John AS. Enhancing counselling strategies for leprosy patients through the participation scale. Leprosy review [Internet]. 2013;84(3):199-208. Available from: https://leprosyreview.org/article/84/3/19-9208
Type
1.
Cross H. The prevention of leprosy related disability as an integral component of the government health delivery programme in Indonesia: perspectives on implementation. Leprosy review [Internet]. 2013;84(3):219-28. Available from: https://leprosyreview.org/article/84/3/21-9228
Type
1.
Udo S, Chukwu J, Obasanya J. Leprosy situation in Nigeria. Leprosy review [Internet]. 2013;84(3):229-37. Available from: https://leprosyreview.org/article/84/3/22-9237
Pagination
- Previous page
- Page 235
- Next page